We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

Rank Stock Value
1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.82M
2
UNH icon
UnitedHealth
UNH
+$3.15M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
251
Karyopharm Therapeutics
KPTI
$200M
$135K 0.06%
+18,316
New +$112K
NKE icon
252
Nike
NKE
$64B
$134K 0.06%
2,100
-225
-10% -$14.7K
COHR icon
253
Coherent
COHR
$57.5B
$129K 0.06%
+700
New +$105K
TVTX icon
254
Travere Therapeutics
TVTX
$5.36B
$126K 0.06%
+3,291
New +$107K
AVGO icon
255
Broadcom
AVGO
$1.81T
$125K 0.06%
+360
New +$129K
BE icon
256
Bloom Energy
BE
$62.4B
$121K 0.05%
1,397
-2,789
-67% -$293K
NTLA icon
257
PUT
Intellia Therapeutics
NTLA
$1.61B
$118K 0.05%
+852
New +$11.7K
AVR
258
Anteris Technologies
AVR
$839M
$116K 0.05%
23,317
– –
DBVT
259
DBV Technologies
DBVT
$843M
$115K 0.05%
+6,019
New +$94K
CERT icon
260
Certara
CERT
$1.07B
$113K 0.05%
+12,791
New +$132K
MLTX icon
261
MoonLake Immunotherapeutics
MLTX
$1.67B
$112K 0.05%
+8,523
New +$101K
ADPT icon
262
Adaptive Biotechnologies
ADPT
$3.62B
$109K 0.05%
+6,689
New +$109K
BLTE
263
Belite Bio
BLTE
$6.04B
$108K 0.05%
+673
New +$79.7K
BBOT
264
BridgeBio Oncology
BBOT
$687M
$107K 0.05%
+8,585
New +$104K
FSLR icon
265
First Solar
FSLR
$22.8B
$103K 0.05%
393
-307
-44% -$77.4K
SRZN icon
266
Surrozen
SRZN
$257M
$98.5K 0.04%
+4,359
New +$70.5K
EYPT icon
267
EyePoint Inc
EYPT
$1.15B
$98.4K 0.04%
+5,387
New +$76.3K
XRAY icon
268
Dentsply Sirona
XRAY
$2.78B
$98.4K 0.04%
+8,605
New +$101K
INSW icon
269
International Seaways
INSW
$4.45B
$97.1K 0.04%
+2,000
New +$98.9K
CSTL icon
270
Castle Biosciences
CSTL
$728M
$95.8K 0.04%
+2,463
New +$79.4K
ENVA icon
271
Enova International
ENVA
$5.86B
$95.6K 0.04%
+608
New +$79.1K
DNLI icon
272
Denali Therapeutics
DNLI
$3.76B
$93.6K 0.04%
+5,670
New +$95.7K
NVST icon
273
Envista
NVST
$4.35B
$92.6K 0.04%
+4,264
New +$87.5K
PRQR icon
274
ProQR Therapeutics
PRQR
$241M
$91.2K 0.04%
45,154
+8,874
+24% +$20.7K
LBRX
275
LB Pharmaceuticals
LBRX
$896M
$90.8K 0.04%
+4,080
New +$71.3K
9 10
11
12 13

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.